Search This Site:
2021-Logos-Banner

Prescribing Information & Guidance

Bulletin 272 Gender Identity Services – Primary Care Prescribing Responsibilities for the Hormonal Treatments (including Eflornithine for the Treatment of Hirsutism in this setting) – JPC Position Statement

Guideline added to website on: 26/02/19
Last modified on: 08/10/21
CCG: |
Section:
Category:
Tags: eflornithine, gender, hirsutism, hormonal, hormone, identity, transgender

Please note the transgender shared care guidelines referenced within this bulletin are currently in the process of being updated - please contact Medicine Optimisation team .

Bulletin 272 - Published Feb 2019

Posted in
Scroll to Top